Literature DB >> 6946459

Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

G M Hänsch, C H Hammer, P Vanguri, M L Shin.   

Abstract

The cytolytic efficiency of the terminal complement protein complex, C5b-9, varies with the species of origin of C8 and C9. In the present study, we explored the susceptibility of erythrocytes from various species to lysis by C5b6,7 plus C8 and C9 from different species. EC5b6,7 intermediates were prepared on human, guinea pig, rabbit, mouse, and rat erythrocytes with human C5b6 and guinea pig C7. The degree of lysis of these intermediates by C8 and C9 was found to vary widely depending on the species of the proteins and the target cells. In all cases, lysis was least efficient when C8 and C9 were homologous with respect to the target cell species. This effect was mostly attributable to C9. The inefficient lysis in a homologous system is not due to a failure of C9 binding. Rather, the poor lysis in the homologous system may be attributable to inefficient insertion or channel formation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6946459      PMCID: PMC320344          DOI: 10.1073/pnas.78.8.5118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  On the mechanism of cytolysis by complement: evidence on insertion of C5b and C7 subunits of the C5b,6,7 complex into phospholipid bilayers of erythrocyte membranes.

Authors:  C H Hammer; A Nicholson; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

Review 2.  Antibody-complement interaction with lipid model membranes.

Authors:  S C Kinsky
Journal:  Biochim Biophys Acta       Date:  1972-02-14

3.  The ninth component of guinea-pig complement. Isolation and identification as an alpha 2-globulin.

Authors:  N Tamura; A Shimada
Journal:  Immunology       Date:  1971-03       Impact factor: 7.397

4.  Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.

Authors:  S I Rosenfeld; C H Packman; D E Jenkins; J K Countryman; J P Leddy
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

5.  Molecular analysis of the reaction of C9 with EAC1-8: reaction of C9 with EAC1-8.

Authors:  H Kitamura; S Inai
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  Studies of complement complex C5b,6 eluted from--EAC-6: reaction of C5b,6 with EAC4b,3b and evidence on the role of C2a and C3b in the activation of C5.

Authors:  M B Goldlust; H S Shin; C H Hammer; M M Mayer
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

7.  On the mechanism of membrane damage by C: exposure of hydrophobic sites on activated C proteins.

Authors:  M L Shin; W A Paznekas; A S Abramovitz; M M Mayer
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

8.  On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.

Authors:  C H Hammer; M L Shin; A S Abramovitz; M M Mayer
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

9.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.

Authors:  W P Kolb; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  40 in total

Review 1.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Homologous species restriction of the complement-mediated killing of nucleated cells.

Authors:  H Yamamoto; P Blaas; A Nicholson-Weller; G M Hänsch
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

3.  C8 binding protein bears I antigenic determinants.

Authors:  P Blaas-Mautner; S Filsinger; B Berger; D Roelcke; G M Hänsch
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

4.  Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.

Authors:  L S Zalman; L M Wood; H J Müller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 5.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

6.  The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.

Authors:  S Schönermark; S Filsinger; B Berger; G M Hänsch
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 7.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

Review 8.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

9.  Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.

Authors:  G M Hänsch; S Schönermark; D Roelcke
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

Review 10.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.